3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 2.470
+0.210 (9.29%)
Sep 18, 2026, 4:08 PM HKT
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 607.42 million as of September 18, 2026. Its market cap has decreased by -68.41% in one year.
Market Cap
607.42M
Enterprise Value
286.73M
Revenue
412.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.47
ChartMarket Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 607.42M, a decrease of -91.35%. That is a compound annual growth rate of -47.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 607.42M | -53.56% |
| Dec 31, 2025 | 1.31B | 73.29% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
| Dec 15, 2022 | 7.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cloudbreak Pharma | 1.01B |
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 898.73M |
| JW (Cayman) Therapeutics Co. | 892.97M |
| Wuhan YZY Biopharma | 639.70M |
| Brii Biosciences | 638.80M |
| B&K Corporation | 470.63M |
| Cutia Therapeutics | 436.04M |